Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE American:PLX)

0.5598
Delayed Data
As of Aug 16
 -0.0159 / -2.76%
Today’s Change
0.26
Today|||52-Week Range
1.51
+25.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues4.7M2.1M2.9M6.4M
 
 
 
 
 
Cost of Goods Sold3.8M1.5M1.6M5.0M
 
 
 
 
 
Depreciation And Amortization483.0K494.0K492.0K494.0K
 
 
 
 
 
 
Operating ExpensesGross Income422.0K129.0K801.0K835.0K
 
 
 
 
 
General Expenses7.1M14.7M8.5M12.1M
 
 
 
 
 
Research And Development5.1M11.5M6.0M9.3M
 
 
 
 
 
Total Operating Expenses11.3M16.6M10.6M17.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.6M-14.5M-7.7M-11.3M
 
 
 
 
 
Extraordinary Credit0.0014.1M0.0014.3M
 
 
 
Extraordinary Charge0.000.00-52.3M0.00
 
 
Interest Expense On Debt910.0K8.0M2.1M3.0M
 
 
 
 
 
Other Expenses0.005.8M1.3M478.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-2.6M-59.1M450.0K
 
 
 
 
 
Net Income-7.3M-2.6M-59.1M450.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS99.8M124.1M124.5M127.5M
 
 
 
 
 
Shares To Calculate EPS Diluted99.8M124.1M124.5M192.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.02-$0.48-$0.06
 
 
 
 
 
EPS Diluted-$0.07-$0.02-$0.48-$0.06